Turnstone Biologics

Turnstone Biologics is a New York-based clinical-stage biotech company that researches and develops TIL cell therapy for the treatment of people with cancer.

Business Model:

Revenue: $6M

Employees: 51-200

Detailed Turnstone Biologics Information

Geographic Data

Turnstone Biologics headquarters map

Address: 920 Broadway

City: New York

State: NY

Zip: 10010

Country: US

Financial Info

Stage:

series d

Raised Last:

$80M

Raised Total:

$133M

Metrics

2,743,363Website Global Rank

6,309Website Monthly Traffic

Twitter Followers

Description

Turnstone Biologics is a New York-based clinical-stage biotech company that researches and develops TIL cell therapy for the treatment of people with cancer.

Contact Phone:
+13478975988

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2019 Corporate Round -
6/2021 Series D $80M PFM Health Sciences
Point72
Eventide Asset Management
Ridgeback Capital Investments
CaaS Capital
JM Family Enterprises, Inc.
Northleaf Capital Partners
Versant Ventures
OrbiMed
F-Prime Capital
Sectoral Asset Management
Sixty Degree Capital
Brace Pharma Capital
Teralys Capital
10/2015 Series A 2 $11.3M Versant Ventures
FACIT
Versant Ventures
1/2019 Equity $42.1M Sixty Degree Capital
12/2019 Corporate Round 1 - Takeda
Takeda
1/2019 Series C 1 - Sixty Degree Capital
Sixty Degree Capital
11/2016 Series B $0 Eight Roads Ventures
F-Prime Capital
FACIT
FACIT.com
OrbiMed
Versant Ventures
Eight Roads Ventures
F-Prime Capital
FACIT
FACIT.com
OrbiMed
Versant Ventures
7/2021 Series D $0 Brace Pharma
CaaS Capital Management
Eventide
F-Prime Capital
JM Family Enterprises
Northleaf Capital Partners
OrbiMed
PFM Health Sciences
Point72
Ridgeback Capital
Sectoral Asset Management
Sixty Degree Capital
Surveyor Capital
Takeda Ventures
Teralys Capital
Versant Ventures
Brace Pharma
CaaS Capital Management
Eventide
F-Prime Capital
JM Family Enterprises
Northleaf Capital Partners
OrbiMed
PFM Health Sciences
Point72
Ridgeback Capital
Sectoral Asset Management
Sixty Degree Capital
Surveyor Capital
Takeda Ventures
Teralys Capital
Versant Ventures
12/2019 Corporate Round - Takeda Pharmaceutical
Takeda Pharmaceutical
11/2016 Series B 6 $41.4M OrbiMed Advisors
F-Prime Capital Partners
Versant Ventures
FACIT International AB
Eight Roads Ventures
F-Prime Capital
FACIT
FACIT.com
OrbiMed
Versant Ventures
7/2021 Series D 16 $80M Brace Pharma
CaaS Capital Management
Eventide
F-Prime Capital
JM Family Enterprises
Northleaf Capital Partners
OrbiMed
PFM Health Sciences
Point72
Ridgeback Capital
Sectoral Asset Management
Sixty Degree Capital
Surveyor Capital
Takeda Ventures
Teralys Capital
Versant Ventures
Brace Pharma
CaaS Capital Management
Eventide
F-Prime Capital
JM Family Enterprises
Northleaf Capital Partners
OrbiMed
PFM Health Sciences
Point72
Ridgeback Capital
Sectoral Asset Management
Sixty Degree Capital
Surveyor Capital
Takeda Ventures
Teralys Capital
Versant Ventures
12/2019 Corporate Round 1 - Takeda
Takeda
1/2019 Series C 1 - Sixty Degree Capital
Sixty Degree Capital
Announced Date Name Price
1/2021 Myst Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research